ClinConnect ClinConnect Logo
Search / Trial NCT06077695

Cognitive Remediation of Working Memory Post Head Trauma

Launched by UNIVERSITY HOSPITAL, TOULOUSE · Oct 4, 2023

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Working Memory Cognitive Remediation Transcranial Direct Current Stimulation

ClinConnect Summary

This clinical trial is studying how to improve working memory in patients who have had moderate to severe head injuries. Working memory is the part of our memory that helps us hold and process information for short periods. The trial will last for five months and involves various activities aimed at enhancing cognitive (thinking) skills, along with a type of brain stimulation called transcranial direct current stimulation (tDCS) and educational support.

To join the study, individuals must have experienced a head injury that is classified as moderate or severe, meaning they had certain symptoms right after the injury and specific problems shown on brain scans. They should also be experiencing difficulties with their working memory. Importantly, people with serious language or cognitive issues, severe depression, or other specific health concerns will not be eligible to participate. Those who are eligible will engage in exercises and receive support to help improve their memory and cognitive skills throughout the trial.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Moderate or severe head trauma, defined by an initial Glasgow score ≤ 12/15, duration of post-traumatic amnesia superior to 24 hours and/or the presence of abnormalities on brain imaging,
  • Moderate or severe head trauma occurring within a period greater than or equal to 3 months,
  • Working memory complaints assessed by the Working Memory Questionnaire,
  • Patients with a working memory disorder in at least one of the following tests: Digit Memory subtest WAIS-IV (standard deviation ≤ -2) , PASAT (percentile ≤ 10), Brown-Peterson (standard deviation ≤ -2).
  • Exclusion Criteria:
  • Presence of aphasia, apraxia or severe neglect demonstrated by standardized neuropsychological tests during the inclusion visit: language - oral naming of BECS-GRECO images, ideational praxis and ideomotor , neglect - bell test,
  • Insufficient visual or auditory abilities and oral and written expression to carry out neuropsychological tests,
  • Severe depression assessed by the Beck Depression Inventory (BDI)
  • Chronic alcoholic poisoning, drug addiction,
  • Progressive general illness,
  • Progressive psychiatric or neurological condition leading to cognitive impairment,
  • Hospitalization for a neurological pathology since the acute phase of the qualifying event,
  • Patient requiring surgery during study participation.
  • Pregnant or breastfeeding women

About University Hospital, Toulouse

The University Hospital of Toulouse is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on patient-centered care, the hospital integrates cutting-edge scientific inquiry with comprehensive clinical services. Its multidisciplinary team of healthcare professionals collaborates with renowned researchers to facilitate pioneering studies across various medical fields, aiming to enhance treatment options and improve patient outcomes. As a prominent institution in the region, the University Hospital of Toulouse is committed to fostering an environment of excellence in both education and research within the healthcare community.

Locations

Patients applied

0 patients applied

Trial Officials

Adeline Julien

Principal Investigator

University Hospital, Toulouse

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported